Announcements Trials

Browse Landscape

Phase

Phase 3 8 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 22 Prostate Adenocarcinoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Leiomyoma 1 Adenocarcinoma 1

Interventions

telapristone acetate 10 ulipristal 3 asoprisnil 3 vilaprisan 2 estradiol, norethindrone drug combination 2 elagolix 2 Norethindrone Acetate 2 Mifepristone 2 Lidocaine 2 Leuprolide 2 Estradiol 2 ulipristal acetate 1 relugolix 1 pirfenidone 1 epigallocatechin gallate 1 Tea 1 Sugars 1 Simvastatin 1 Ropivacaine 1 Progesterone 1 Morphine 1 Methadone 1 Injections, Subcutaneous 1 Embolization, Therapeutic 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyoma × relugolix × Clear all

NCT01452659 2013-01-21

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Takeda

Phase 2 Completed

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡